SCHEMBL19863782

SCHEMBL19863782

CCOC(OCC)c1nc2cc(Cl)ccc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
ALOX15 P16050 4/20 0.39
HRH4 Q9H3N8 3/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
IDO1 P14902 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
SIRT3 Q9NTG7 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HSD17B10 Q99714 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5110751 0.79 TAAR1 (0.42) CYP1A2HRH4KMT2AMEN1HTT
SCHEMBL6525600 0.79 TAAR1 (0.42) CYP1A2HRH4KMT2AMEN1HTT
SCHEMBL23676476 0.79 SCN10A (0.43) CYP1A2ALOX15HRH4KMT2AMEN1
SCHEMBL4725067 0.78 ALDH1A1 (0.54) CYP1A2KMT2AALDH1A1GAAIDO1
SCHEMBL4111356 0.78 HSD17B10 (0.57) CYP1A2HRH4ALDH1A1GAAKDM4E
SCHEMBL580331 0.78 TAAR1 (0.46) CYP1A2HRH4ALDH1A1GAAKDM4E
SCHEMBL12065647 0.78 SCN10A (0.40) KMT2AMEN1HTT
SCHEMBL1479674 0.77 TAAR1 (0.43) CYP1A2HRH4KDM4E
SCHEMBL4162306 0.77 TAAR1 (0.43) CYP1A2HRH4KDM4E
SCHEMBL583539 0.77 TAAR1 (0.43) CYP1A2HRH4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex Sanford Burnham Prebys Medical Discovery Institute (US) 2020-03-03 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 CYP1A2 4156/4885ALOX15 4384/4885HRH4 4099/4885
US-10577349-B2 Quinolinones as inhibitors of translation initiation complex EIF4E, EIF4A1, EIF4A2 CYP1A2 4156/4885ALOX15 4384/4885HRH4 4099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.